Found "AI":  1,093 results
Crystal balling into the future: Insights from PMAC side meeting on modelling
                    On January 23rd, just one day after joining HITAP, I was presented with an opportunity to travel to Bangkok for the renowned annual Prince Mahidol Award Conference (PMAC). The PMAC 2024, hosted at the Centara Grand & Bangkok Convention Centre from January 22nd-27th, 2024, proved to be an enlight                
                
                
            Cross-Country Conversations: Health Technology Assessment (HTA) Experiences from India and Thailand
                    India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co                
                
                
            Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment. (2010)
                    Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
Sitaporn Youngkong*1,2, Rob Baltussen*1, Sripen Tantivess*2, Xander Koolman*3 and Yot Teerawattananon*2
1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of                
                
                
            COVID-19 Vaccine Hesitancy Among Health Care Workers in Thailand: The Comparative Results of Two Cross-Sectional Online Surveys Before and After Vaccine Availability
                    Objectives: This study aims to assess the trade-offs between vulnerability and efficiency attributes of contact tracing programmes based on preferences of COVID-19 contact tracing practitioners, researchers and other relevant stakeholders at the global level.
Methods: We conducted an online discr                
                
                
            COVID-19 Vaccination Policy Research and Decision Support Initiative in Asia (CORESIA): a regional study on vaccination certificates
                    As countries being their COVID-19 vaccinationation campaigns, an increasing number of public and private sectors in many settings are considering the introduction of COVID-19 vaccination certificates or similar instruments as a safe passage into the new normal. By facilitating the resumption of travel and economic activities, they can play an essen                
                
                
            COVID-19 Multi-Model Comparison Consortium (CMCC)
                    The CMCC aims to enhance the informed use of COVID-19 models in policy making, by providing end users (with focus on LMICs) with an accessible overview of the aims, capabilities and limits of the existing COVID-19 models, how projections differ and what the models’ key assumptions/drivers are. The CMCC is convened by BMGF, the Centers for Disease                
                
                
            Coverage Decisions and the Court: A Public Health Perspective on Glucosamine Reimbursement in Thailand (2016)
                    Sripen Tantivess & Viroj Tangcharoensathien
Abstract
Thailand achieves universal health coverage through the introduction of 3 benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these sche                
                
                
            Counting what counts in development: Health and Indonesia
                    Development cannot be contained in a numerical measure of Gross National Product/Gross Domestic Product (GNP/GDP), conceding this the UN gave a universal call to its member nations for the Sustainable Development Goals (SDGs). The SDG 3 explicitly states “ensuring healthy lives and promote well-bein                
                
                
            Cost–utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand
                    ABSTRACT
Objectives: This study aimed to analyse the cost–utility and budget impact of adding tocilizumab to the standard treatment for patients with refractory systemic juvenile idiopathic arthritis (sJIA) in Thailand.
Design: Economic evaluation using a decision-analytical model.
Setting:                
                
                
            Cost-Utility and Budget Impact Analysis of Hepatitis C Virus Treatment With Sofosbuvir-based Regimens in Thailand
                    Hepatitis C caused liver diseases is one of major disease burden in low- and middle-income countries. Many economic evaluation studies worldwide showed the evidence that using medicines for hepatitis C treatment provides enough benefit to patients when justify its cost. However, in 2011, there was no any studies conducted to be considered in the co                
                
                
            
        
  10 / Page
        
      
      